Journal Article
. 2016 Jul; 11(7):e0159949.
doi: 10.1371/journal.pone.0159949.

Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI

Haesung Yoon 1 Dahye Yoon 2 Mijin Yun 3 Ji Soo Choi 4 Vivian Youngjean Park 1 Eun-Kyung Kim 1 Joon Jeong 5 Ja Seung Koo 6 Jung Hyun Yoon 1 Hee Jung Moon 1 Suhkmann Kim 2 Min Jung Kim 1 
  • PMID: 27459480
  •     49 References
  •     15 citations


Purpose: Our goal in this study was to find correlations between breast cancer metabolites and conventional quantitative imaging parameters using high-resolution magic angle spinning (HR-MAS) magnetic resonance spectroscopy (MRS) and to find breast cancer subgroups that show high correlations between metabolites and imaging parameters.

Materials And Methods: Between August 2010 and December 2013, we included 53 female patients (mean age 49.6 years; age range 32-75 years) with a total of 53 breast lesions assessed by the Breast Imaging Reporting and Data System. They were enrolled under the following criteria: breast lesions larger than 1 cm in diameter which 1) were suspicious for malignancy on mammography or ultrasound (US), 2) were pathologically confirmed to be breast cancer with US-guided core-needle biopsy (CNB) 3) underwent 3 Tesla MRI with dynamic contrast-enhanced (DCE) and diffusion-weighted imaging (DWI) and positron emission tomography-computed tomography (PET-CT), and 4) had an attainable immunohistochemistry profile from CNB. We acquired spectral data by HR-MAS MRS with CNB specimens and expressed the data as relative metabolite concentrations. We compared the metabolites with the signal enhancement ratio (SER), maximum standardized FDG uptake value (SUV max), apparent diffusion coefficient (ADC), and histopathologic prognostic factors for correlation. We calculated Spearman correlations and performed a partial least squares-discriminant analysis (PLS-DA) to further classify patient groups into subgroups to find correlation differences between HR-MAS spectroscopic values and conventional imaging parameters.

Results: In a multivariate analysis, the PLS-DA models built with HR-MAS MRS metabolic profiles showed visible discrimination between high and low SER, SUV, and ADC. In luminal subtype breast cancer, compared to all cases, high SER, ADV, and SUV were more closely clustered by visual assessment. Multiple metabolites were correlated with SER and SUV in all cases. Multiple metabolites showed correlations with SER and SUV in the ER positive, HER2 negative, and Ki-67 negative groups.

Conclusion: High levels of PC, choline, and glycine acquired from HR-MAS MRS using CNB specimens were noted in the high SER group via DCE MRI and the high SUV group via PET-CT, with significant correlations between choline and SER and between PC and SUV. Further studies should investigate whether HR-MAS MRS using CNB specimens can provide similar or more prognostic information than conventional quantitative imaging parameters.

Invasive breast carcinoma: influence of prognosis and patient-related factors on kinetic MR imaging characteristics.
Ingrid Millet, Fernanda Curros-Doyon, +4 authors, Patrice Taourel.
Radiology, 2013 Sep 14; 270(1). PMID: 24029641
Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies.
Thomas L Chenevert, Craig J Galbán, +7 authors, Brian D Ross.
J Magn Reson Imaging, 2011 Sep 20; 34(4). PMID: 21928310    Free PMC article.
Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma.
Laura Esserman, Nola Hylton, Tracy George, Noel Weidner.
Breast J, 2001 May 12; 5(1). PMID: 11348250
Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
Rachel Katz-Brull, Dalia Seger, +2 authors, Hadassa Degani.
Cancer Res, 2002 Apr 04; 62(7). PMID: 11929812
Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers.
Guro F Giskeødegård, Steinar Lundgren, +5 authors, Tone F Bathen.
NMR Biomed, 2012 Mar 13; 25(11). PMID: 22407957
Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer.
Pascal A T Baltzer, Tibor Vag, +5 authors, Werner A Kaiser.
Eur Radiol, 2010 Mar 06; 20(7). PMID: 20204647
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics.
Joanne T Brindle, Henrik Antti, +8 authors, David J Grainger.
Nat Med, 2002 Nov 26; 8(12). PMID: 12447357
Highly Cited.
Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
Beathe Sitter, Tone F Bathen, +4 authors, Ingrid S Gribbestad.
NMR Biomed, 2010 Jan 27; 23(4). PMID: 20101607
Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients.
M J Engstrøm, S Opdahl, +5 authors, A M Bofin.
Breast Cancer Res Treat, 2013 Aug 01; 140(3). PMID: 23901018    Free PMC article.
18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.
Hye Ryoung Koo, Jeong Seon Park, +9 authors, Woo Kyung Moon.
Eur Radiol, 2013 Oct 08; 24(3). PMID: 24097303
Measuring the accuracy of diagnostic systems.
J A Swets.
Science, 1988 Jun 03; 240(4857). PMID: 3287615
Highly Cited. Review.
Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy.
Ji Soo Choi, Hyeon-Man Baek, +5 authors, Youn Ki Nam.
PLoS One, 2013 Dec 25; 8(12). PMID: 24367616    Free PMC article.
Analyzing the regulation of metabolic pathways in human breast cancer.
Gunnar Schramm, Eva-Maria Surmann, +4 authors, Rainer König.
BMC Med Genomics, 2010 Sep 14; 3. PMID: 20831783    Free PMC article.
Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer.
Hyeon-Man Baek, Hon J Yu, +2 authors, Min-Ying Su.
Magn Reson Imaging, 2007 Dec 07; 26(4). PMID: 18060716    Free PMC article.
Apparent Diffusion Coefficient in Invasive Ductal Breast Carcinoma: Correlation with Detailed Histologic Features and the Enhancement Ratio on Dynamic Contrast-Enhanced MR Images.
Roka Namoto Matsubayashi, Teruhiko Fujii, +2 authors, Seiya Momosaki.
J Oncol, 2010 Sep 28; 2010. PMID: 20871661    Free PMC article.
Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.
J-H Chen, R S Mehta, +6 authors, M-Y Su.
NMR Biomed, 2010 Sep 24; 24(3). PMID: 20862660    Free PMC article.
Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis.
Monique D Dorrius, Hildebrand Dijkstra, Matthijs Oudkerk, Paul E Sijens.
Eur Radiol, 2014 Aug 12; 24(11). PMID: 25103535
Systematic Review.
Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
Eun Jeong Kim, Sung Hun Kim, +8 authors, Robert Grimm.
J Magn Reson Imaging, 2015 Apr 29; 42(6). PMID: 25919239
Prognostic Value of Primary Tumor Uptake on F-18 FDG PET/CT in Patients with Invasive Ductal Breast Cancer.
Bong-Il Song, Chae Moon Hong, +8 authors, Jaetae Lee.
Nucl Med Mol Imaging, 2011 Jun 01; 45(2). PMID: 24899990    Free PMC article.
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation.
Mohit Jain, Roland Nilsson, +7 authors, Vamsi K Mootha.
Science, 2012 May 26; 336(6084). PMID: 22628656    Free PMC article.
Highly Cited.
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.
Emilia Montagna, Vincenzo Bagnardi, +13 authors, Marco Colleoni.
Breast Cancer Res Treat, 2011 Aug 09; 129(3). PMID: 21822638
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
C W Elston, I O Ellis.
Histopathology, 1991 Nov 01; 19(5). PMID: 1757079
Highly Cited.
Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
P C Stomper, S Herman, +5 authors, L E Blumenson.
Radiology, 1995 Nov 01; 197(2). PMID: 7480682
Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.
Guro F Giskeødegård, Maria T Grinde, +6 authors, Tone F Bathen.
J Proteome Res, 2009 Dec 10; 9(2). PMID: 19994911
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response.
Jorma J de Ronde, Juliane Hannemann, +7 authors, Sjoerd Rodenhuis.
Breast Cancer Res Treat, 2009 Aug 12; 119(1). PMID: 19669409
Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer.
S Y Choi, Y-W Chang, +3 authors, D Y Seo.
Br J Radiol, 2011 Dec 01; 85(1016). PMID: 22128125    Free PMC article.
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.
E O Aboagye, Z M Bhujwalla.
Cancer Res, 1999 Jan 19; 59(1). PMID: 9892190
Highly Cited.
Contrast-enhanced MR imaging as a prognostic indicator of breast cancer.
B Boné, P Aspelin, L Bronge, B Veress.
Acta Radiol, 1998 May 08; 39(3). PMID: 9571944
High-resolution magic angle spinning MRS of breast cancer tissue.
Beathe Sitter, Ursula Sonnewald, +2 authors, Ingrid S Gribbestad.
NMR Biomed, 2002 Aug 31; 15(5). PMID: 12203224
HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors.
Ji Soo Choi, Hyeon-Man Baek, +8 authors, Ja Seung Koo.
PLoS One, 2012 Dec 29; 7(12). PMID: 23272149    Free PMC article.
Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
Beathe Sitter, Steinar Lundgren, +3 authors, Ingrid S Gribbestad.
NMR Biomed, 2005 Oct 18; 19(1). PMID: 16229059
1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histologic prognostic factors.
Mitsuhiro Tozaki, Kazuei Hoshi.
AJR Am J Roentgenol, 2010 Apr 23; 194(5). PMID: 20410429
Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma.
Su Kyung Jeh, Sung Hun Kim, +4 authors, Byung Joo Song.
J Magn Reson Imaging, 2010 Dec 25; 33(1). PMID: 21182127
Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors.
Ahmed Abdel Khalek Abdel Razek, Gada Gaballa, Adel Denewer, Nadia Nada.
NMR Biomed, 2010 Mar 17; 23(6). PMID: 20232453
Preoperative assessment of prognostic factors in breast cancer.
H Denley, S E Pinder, +2 authors, I O Ellis.
J Clin Pathol, 2001 Mar 29; 54(1). PMID: 11271783    Free PMC article.
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Maggie C U Cheang, Stephen K Chia, +10 authors, Torsten O Nielsen.
J Natl Cancer Inst, 2009 May 14; 101(10). PMID: 19436038    Free PMC article.
Highly Cited.
Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype.
Inna Serganova, Asif Rizwan, +5 authors, Jason A Koutcher.
Clin Cancer Res, 2011 Aug 17; 17(19). PMID: 21844011    Free PMC article.
MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status.
Tone F Bathen, Line R Jensen, +5 authors, Steinar Lundgren.
Breast Cancer Res Treat, 2006 Oct 25; 104(2). PMID: 17061040
Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer.
Takeshi Kamitani, Yoshio Matsuo, +10 authors, Hiroshi Honda.
Magn Reson Med Sci, 2013 Jul 17; 12(3). PMID: 23857151
13C high-resolution-magic angle spinning MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns.
Maria T Grinde, Siver A Moestue, +3 authors, Ingrid S Gribbestad.
NMR Biomed, 2011 Apr 05; 24(10). PMID: 21462378
An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy.
MuLan Li, Yonghyun Song, +6 authors, Woo Kyung Moon.
PLoS One, 2011 Oct 27; 6(10). PMID: 22028780    Free PMC article.
Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
Hye Ryoung Koo, Nariya Cho, +5 authors, Woo Kyung Moon.
J Magn Reson Imaging, 2012 Mar 07; 36(1). PMID: 22392859
Metabolic characterization of triple negative breast cancer.
Maria D Cao, Santosh Lamichhane, +4 authors, Tone F Bathen.
BMC Cancer, 2014 Dec 17; 14. PMID: 25495193    Free PMC article.
Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer.
Kelly M Kennedy, Peter M Scarbrough, +8 authors, Mark W Dewhirst.
PLoS One, 2013 Sep 27; 8(9). PMID: 24069390    Free PMC article.
Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.
Naoki Ikenaga, Naoki Otomo, +5 authors, Masao Tanaka.
Am Surg, 2007 Dec 21; 73(11). PMID: 18092653
Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy.
Jona Hattangadi, Catherine Park, +4 authors, Nola Hylton.
AJR Am J Roentgenol, 2008 May 22; 190(6). PMID: 18492917
Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom.
Dariya Malyarenko, Craig J Galbán, +5 authors, Thomas L Chenevert.
J Magn Reson Imaging, 2012 Oct 02; 37(5). PMID: 23023785    Free PMC article.
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.
Maria D Cao, Guro F Giskeødegård, +5 authors, Ingrid S Gribbestad.
BMC Cancer, 2012 Jan 27; 12. PMID: 22277092    Free PMC article.
Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Shigeto Ueda, Hitoshi Tsuda, +9 authors, Hidetaka Mochizuki.
Jpn J Clin Oncol, 2008 Apr 15; 38(4). PMID: 18407934
Abbreviated MRI Protocols for Detecting Breast Cancer in Women with Dense Breasts.
Shuang-Qing Chen, Min Huang, +2 authors, Chuan-Xiao Xu.
Korean J Radiol, 2017 May 02; 18(3). PMID: 28458599    Free PMC article.
Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.
Tonje H Haukaas, Leslie R Euceda, Guro F Giskeødegård, Tone F Bathen.
Metabolites, 2017 May 17; 7(2). PMID: 28509845    Free PMC article.
Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.
Christopher Dietz, Felix Ehret, +7 authors, Leo L Cheng.
NMR Biomed, 2017 Sep 16; 30(11). PMID: 28915318    Free PMC article.
Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers.
Ji Soo Choi, Dahye Yoon, +5 authors, Min Jung Kim.
Oncotarget, 2017 Oct 04; 8(38). PMID: 28969000    Free PMC article.
Combined diagnosis of breast cancer in the early stage by MRI and detection of gene expression.
Dena Ke, Rong Yang, Lina Jing.
Exp Ther Med, 2018 Aug 17; 16(2). PMID: 30112019    Free PMC article.
A metabolic profile of routine needle biopsies identified tumor type specific metabolic signatures for breast cancer stratification: a pilot study.
Narumi Harada-Shoji, Tomoyoshi Soga, +8 authors, Takanori Ishida.
Metabolomics, 2019 Nov 07; 15(11). PMID: 31686242
Clinical applications of breast cancer metabolomics using high-resolution magic angle spinning proton magnetic resonance spectroscopy (HRMAS 1H MRS): systematic scoping review.
Almir G V Bitencourt, Johanna Goldberg, Katja Pinker, Sunitha B Thakur.
Metabolomics, 2019 Nov 07; 15(11). PMID: 31696341
Systematic Review.
MRI-guided robotic arm drives optogenetic fMRI with concurrent Ca2+ recording.
Yi Chen, Patricia Pais-Roldan, +2 authors, Xin Yu.
Nat Commun, 2019 Jun 12; 10(1). PMID: 31182714    Free PMC article.
Elevated glycine detected on in vivo magnetic resonance spectroscopy in a breast cancer patient: case report and literature review.
Almir G V Bitencourt, Katja Pinker, Sunitha Thakur.
BJR Case Rep, 2020 Mar 24; 6(1). PMID: 32201616    Free PMC article.
Metabolomics and Multi-Omics Integration: A Survey of Computational Methods and Resources.
Tara Eicher, Garrett Kinnebrew, +5 authors, And Ewy A Mathé.
Metabolites, 2020 May 21; 10(5). PMID: 32429287    Free PMC article.
Metabolomic prostate cancer fields in HRMAS MRS-profiled histologically benign tissue vary with cancer status and distance from cancer.
Sarah S Dinges, Lindsey A Vandergrift, +5 authors, Leo L Cheng.
NMR Biomed, 2019 Jan 05; 32(10). PMID: 30609175    Free PMC article.
HR-MAS NMR Based Quantitative Metabolomics in Breast Cancer.
Mikheil Gogiashvili, Jessica Nowacki, +3 authors, Karolina Edlund.
Metabolites, 2019 Jan 27; 9(2). PMID: 30678289    Free PMC article.
NMR Spectroscopy for Metabolomics Research.
Abdul-Hamid Emwas, Raja Roy, +8 authors, David S Wishart.
Metabolites, 2019 Jun 30; 9(7). PMID: 31252628    Free PMC article.
Highly Cited. Review.
Prioritization of metabolic genes as novel therapeutic targets in estrogen-receptor negative breast tumors using multi-omics data and text mining.
Dinesh Kumar Barupal, Bei Gao, +4 authors, Oliver Fiehn.
Oncotarget, 2019 Jun 25; 10(39). PMID: 31231467    Free PMC article.
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.
Alessia Vignoli, Emanuela Risi, +6 authors, Leonardo Tenori.
Int J Mol Sci, 2021 May 01; 22(9). PMID: 33925233    Free PMC article.